Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Simpson, Mindy
Item TypeName
Concept von Willebrand Factor
Concept Factor IX
Concept Factor VIII
Concept Factor VIIa
Concept Factor VII Deficiency
Academic Article Management of joint bleeding in hemophilia.
Academic Article A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A.
Academic Article Bypassing agent prophylaxis in people with hemophilia A or B with inhibitors.
Academic Article PERSEPT 1: a phase 3 trial of activated eptacog beta for on-demand treatment of haemophilia inhibitor-related bleeding.
Academic Article Prediction of factor VIII inhibitor development in the SIPPET cohort by mutational analysis and factor VIII antigen measurement.
Academic Article Timing and severity of inhibitor development in recombinant versus plasma-derived factor VIII concentrates: a SIPPET analysis.
Academic Article Safety and dose-dependency of eptacog beta (activated) in a dose escalation study of non-bleeding congenital haemophilia A or B patients, with or without inhibitors.
Academic Article Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A.
Academic Article Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate(?) ) in patients with severe haemophilia A.
Academic Article Use of global assays to understand clinical phenotype in congenital factor VII deficiency.
Academic Article Exploring the biological basis of haemophilic joint disease: experimental studies.
Academic Article Favorable pharmacokinetics in hemophilia B for nonacog beta pegol versus recombinant factor IX-Fc fusion protein: A randomized trial.
Academic Article Comparing Factor Use and Bleed Rates in U.S. Hemophilia A Patients Receiving Prophylaxis with 3 Different Long-Acting Recombinant Factor VIII Products.
Academic Article Comparing Physician and Patient Perspectives on Prophylactic Treatment with BAY?94-9027 for Severe Haemophilia?A: A Post Hoc Analysis.
Academic Article A Real-World Analysis of Commonly Prescribed FVIII Products Based on U.S. Medical Charts: Consumption and Bleeding Outcomes in Hemophilia A Patients.
Academic Article Hemophilia: A Review of Perioperative Management for Cardiac Surgery.
Academic Article Decreased Bleeding Rates in Patients with Hemophilia A Switching from Standard-Half-Life FVIII to BAY 94-9027 Prophylaxis.
Academic Article Effects of PK-guided prophylaxis on clinical outcomes and FVIII consumption for patients with moderate to severe Haemophilia A.
Search Criteria
  • Fibrinogen